CCND1 and cancer: Cyclins are often upregulated in cancers (32); however, cyclin D1 has not been shown to be a negative prognostic factor in cancer (32), cyclin D2 is often methylated and thus downregulated in lung cancer (33), and cyclin D3 was suggested not to have a profound role in tumorigenesis (34).